Announcements Trials

Browse Landscape

Phase

Status

Recruiting 3 Unknown 2 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

pembrolizumab 70 Nivolumab 47 Ipilimumab 27 Specimen Handling 15 Magnetic Resonance Spectroscopy 15 trametinib 14 Biopsy 13 dabrafenib 11 cemiplimab 11 avelumab 11 Cyclophosphamide 11 binimetinib 10 Radiotherapy 9 CTLA-4 Antigen 9 fludarabine 8 encorafenib 7 atezolizumab 7 Radiosurgery 7 Immunoglobulin G 7 Disulfides 7 Cisplatin 7 fludarabine phosphate 6 durvalumab 6 tislelizumab 5 relatlimab 5 lenvatinib 5 dostarlimab 5 Pemetrexed 5 Paclitaxel 5 Introns 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × daromun × Dermatologic × Clear all

NCT02938299 2024-09-19

Pivotal

Philogen S.p.A.

Phase 3 Active not recruiting

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡